-Raymond A Dwek Researcher Activity Profile

Research Author Detailed Information 

Raymond A Dwek Publication Rate By Year

Raymond A Dwek has published 1 paper(s) in 2002, 19 paper(s) in 2007, 11 paper(s) in 2008, for a total of 31 research publications in total.

Raymond A Ra Dwek Author Information

LAST NAME: dwek

FIRST NAME: Raymond A

INITIALS: ra

AFFILIATION:

Papers

Raymond A Dwek's Publication Record

1. Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals. Year Published: 2007
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, United Kingdom.
2. Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Year Published: 2007
Stem Cell & Regeneration Program, Center for Neuroscience and Aging Research, Burnham Institute for Medical Research, La Jolla, California 92037, USA.
3. Crystallographic, thermodynamic, and molecular modeling studies of the mode of binding of oligosaccharides to the potent antiviral protein griffithsin. Year Published: 2007
Protein Structure Section, Macromolecular Crystallography Laboratory, National Cancer Institute, NCI-Frederick, Frederick, Maryland 21702-1201, USA.
4. Recovery of intact 2-aminobenzamide-labeled O-glycans released from glycoproteins by hydrazinolysis. Year Published: 2002
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, United Kingdom.
5. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3. Year Published: 2007
Glycobiology Institute, Department of Biochemistry, University of Oxford, UK.
6. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity. Year Published: 2007
Institute of Biochemistry, Splaiul Independentei, 296, Sector 6, Bucharest 77700, Romania.
7. Separation-based Glycoprofiling Approaches using Fluorescent Labels. Year Published: 2007
LGC Ltd, Teddington, Middlesex, UK.
8. Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis. Year Published: 2007
Departments of Biochemistry and Pharmacology, University of Oxford, Mansfield Road, Oxford, United Kingdom.
9. Ovarian Cancer is Associated with Changes in Glycosylation in Both Acute-Phase Proteins and IgG. Year Published: 2007
Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford OX1 3QU, UK;
10. Changes of serum glycans during sepsis and acute pancreatitis. Year Published: 2007
Department of Biochemistry and Molecular Biology, University of Zagreb Faculty of Pharmacy and Biochemistry, 10000 Zagreb, Croatia.
11. Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis. Year Published: 2007
Departments of Biochemistry and Pharmacology, University of Oxford, Mansfield Road, Oxford, United Kingdom.
12. Glucosylated free oligosaccharides are biomarkers of endoplasmic- reticulum alpha-glucosidase inhibition. Year Published: 2007
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, U.K.
13. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity. Year Published: 2007
Institute of Biochemistry, Splaiul Independentei, 296, Sector 6, Bucharest 77700, Romania.
14. Glucosylated free oligosaccharides are biomarkers of endoplasmic- reticulum alpha-glucosidase inhibition. Year Published: 2007
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.
15. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Year Published: 2007
Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, UK.
16. Changes of serum glycans during sepsis and acute pancreatitis. Year Published: 2007
Department of Biochemistry and Molecular Biology, University of Zagreb Faculty of Pharmacy and Biochemistry, 10000, Zagreb, Croatia.
17. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3. Year Published: 2007
Glycobiology Institute, Department of Biochemistry, University of Oxford, UK.
18. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice. Year Published: 2008
Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK.
19. Increased levels of galactose-deficient anti-gal immunoglobulin g in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. Year Published: 2008
Drexel University College of Medicine and Department of Microbiology and Immunology and Drexel Institute for Biotechnology and Virology, 700 East Butler Ave., Doylestown, PA 18901. anand.mehta@drexel.edu.
20. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. Year Published: 2008
Drexel University College of Medicine and Department of Microbiology and Immunology and Drexel Institute for Biotechnology and Virology, Doylestown, PA 18901, USA. anand.mehta@drexel.edu
21. N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice. Year Published: 2008
Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK. david.priestman@pharm.ox.ac.uk
22. Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. Year Published: 2008
School of Biological & Molecular Sciences, Oxford Brookes University, Gipsy Lane, Headington, Oxford, OX3 0BP, UK. s.brooks@brookes.ac.uk.
23. Monosialylated biantennary N-glycoforms containing GalNAc-GlcNAc antennae predominate when human EPO is expressed in goat milk. Year Published: 2008
Department of Carbohydrate Chemistry, Center for Genetic Engineering and Biotechnology, P.O. Box 6162, Havana 10600, Cuba.
24. Increased levels of galactose-deficient anti-Gal immunoglobulin G in the sera of hepatitis C virus-infected individuals with fibrosis and cirrhosis. Year Published: 2008
Drexel University College of Medicine and Department of Microbiology and Immunology and Drexel Institute for Biotechnology and Virology, Doylestown, PA 18901, USA. anand.mehta@drexel.edu
25. Altered glycosylation of proteins in cancer: what is the potential for new anti-tumour strategies. Year Published: 2008
School of Biological & Molecular Sciences, Oxford Brookes University, Gipsy Lane, Headington, Oxford, OX3 0BP, UK. s.brooks@brookes.ac.uk
26. Glucosylated free oligosaccharides are biomarkers of endoplasmic- reticulum alpha-glucosidase inhibition. Year Published: 2007
Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK.
27. Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma. Year Published: 2008
Genetic Vaccine Group, Cancer Sciences Division, University of Southampton School of Medicine, Southampton, UK.
28. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Year Published: 2007
Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford, UK.
29. Changes of serum glycans during sepsis and acute pancreatitis. Year Published: 2007
Department of Biochemistry and Molecular Biology, University of Zagreb Faculty of Pharmacy and Biochemistry, 10000, Zagreb, Croatia.
30. Monosialylated biantennary N-glycoforms containing GalNAc-GlcNAc antennae predominate when human EPO is expressed in goat milk. Year Published: 2008
Department of Carbohydrate Chemistry, Center for Genetic Engineering and Biotechnology, P.O. Box 6162, Havana 10600, Cuba.
31. Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma. Year Published: 2008
Genetic Vaccine Group, Cancer Sciences Division, University of Southampton School of Medicine, Southampton, UK. kjm8@soton.ac.uk <kjm8@soton.ac.uk>